The jury in Luigi Mangione's upcoming state murder trial will remain anonymous, a New York judge ruled Tuesday. Justice Gregory Carro issued the order without elaborating on specific threats, as Mangione, 28, faces charges in the fatal shooting of UnitedHealthcare CEO Brian Thompson in Manhattan in December 2024. The case drew national attention, with graphic footage of the killing and a five-day manhunt culminating in Mangione's arrest in Pennsylvania. Jury selection is scheduled to begin September 8.
Prosecutors say they have surveillance video, fingerprints, DNA, a cellphone, a firearm with matching ballistics and a notebook in which Mangione allegedly expressed hatred for health insurers and intentions to kill. Mangione has pleaded not guilty to state charges of murder, weapons possession and forgery brought by Manhattan District Attorney Alvin Bragg, as well as not guilty to federal stalking charges in a separate case. His legal team has offered little on their defense strategy, though a July court filing suggests they may argue Mangione suffered an extreme mental health breakdown at the time of the incident. Mangione appeared at a pre-trial hearing on August 11, 2026, in Manhattan Criminal Court. The judge also ordered an overflow courtroom for the public and press should the main venue reach capacity during trial proceedings.
The decision to shield the jury's identities signals the court's expectation of intense public pressure, unusual in a case not involving organized crime or terrorism. When a corporate executive's killing becomes a symbol of systemic frustration, the trial risks becoming less about individual guilt and more about national sentiment. The defense's focus on mental health may clash with prosecutors' reliance on forensic evidence, setting up a legal battle over narrative as much as facts. The state trial begins next month, with a federal trial set for January.
Editorial note: AI-assisted opinion, not established fact. Full disclaimer →
